Navigation Links
VIA Pharmaceuticals Receives Anticipated Notice From NASDAQ
Date:4/3/2009

underlying cause of atherosclerosis and its complications, including heart attack and stroke. In addition, VIA's pipeline of drug candidates includes other compounds to address other underlying causes of cardiovascular disease: high cholesterol, diabetes and inflammation. For more information, visit: http://www.viapharmaceuticals.com.

Forward Looking Statements

This press release may contain "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements relate to future events or to VIA's future financial performance and involve known and unknown risks, uncertainties and other factors that may cause VIA's actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. In some cases, you can identify forward-looking statements by the use of words such as "may," "could," "expect," "intend," "plan," "seek," "anticipate," "believe," "estimate," "predict," "potential," "continue" or the negative of these terms or other comparable terminology. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond VIA's control and which could materially affect actual results, levels of activity, performance or achievements.

The plan that the Company intends to submit to NASDAQ may not be acceptable to NASDAQ or may not be able to be implemented within a time frame acceptable to NASDAQ due to a number of factors, including, but not limited to: 

        -- our ability to borrow additional amounts under the loan from Bay
           City Capital, which is subjec
'/>"/>
SOURCE  VIA Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 

Related biology technology :

1. Savient Pharmaceuticals to Raise $31 Million Through Registered Direct Offering
2. Amylin Pharmaceuticals Provides Shareholders with Update Regarding Recent Developments
3. Sunesis Pharmaceuticals Reports Fourth Quarter and Full-Year 2008 Financial Results
4. NovaBay Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2008 Financial Results
5. Alseres Pharmaceuticals, Inc. Complies with NASDAQ Rule Regarding Recently Filed 10-K
6. Novavax Announces New Capital Infusion Through a Strategic Alliance with Cadila Pharmaceuticals of India
7. VIA Pharmaceuticals to Present Poster at AHA Arteriosclerosis, Thrombosis and Vascular Biology Conference 2009
8. Angiotech Pharmaceuticals, Inc. announces License Agreement with Baxter International Inc.
9. Peregrine Pharmaceuticals Awarded New U.S. Patent Further Strengthening Its Anti-Phospholipid Patent Portfolio
10. Endo Pharmaceuticals Appoints Dr. Nancy Hutson to Board of Directors
11. VIA Pharmaceuticals Complies With NASDAQ Rules
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... , June 19, 2013  Continuing its long history ... (MI), Beckman Coulter , Inc. announces the U.S. ... new Access AccuTnI+3 troponin I assay for use on ... have depended on Beckman Coulter,s troponin I ... assay has the proven performance to continue providing dependability ...
(Date:6/19/2013)... Today DuPont Executive Vice President James ... in the greatest challenge facing our time – ensuring ... Borel spoke at the International Food and Agribusiness ... need for students to contribute their time and talents ... reached in collaboration with others. , “Food is one ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 BioConvergence ... the speaking faculty at 2013’s BioLogistics Summit in ... conference, coordinated by Cold Chain IQ and IQPC, ... This “complexity” is, in part, attributed to current ... , “Implicit within these trends is an increase ...
(Date:6/19/2013)... (PRWEB) June 18, 2013 A new ... materials, costs and other trends will highlight technical sessions ... California this fall. In its 33rd year, the three-day ... an exhibition of key suppliers, approximately 100 technical presentations ... SPIE, the international society for optics and photonics , ...
Breaking Biology Technology:Beckman Coulter Announces FDA Clearance of New Access AccuTnI+3 Troponin I Assay for the Access 2 Immunoassay System 2Beckman Coulter Announces FDA Clearance of New Access AccuTnI+3 Troponin I Assay for the Access 2 Immunoassay System 3DuPont Leader Calls for New Generation of Food Visionaries to Fight Hunger 2BioConvergence® Presents at BioLogistics Summit on Risk Matrix for Biosamples during Shipment 2‘Big Glass’ and Visions for the Future are on the Program for SPIE Photomask Technology 2‘Big Glass’ and Visions for the Future are on the Program for SPIE Photomask Technology 3
... 2 GlaxoSmithKline plc (GSK),announced today that Fountain ... a cash tender offer to purchase all,outstanding shares ... SIRT ) (Sirtris), for $22.50 in cash without ... offer is being made pursuant to a,previously announced ...
... P3(TM) Technology Raising the Bar in Motion Preservation, ... Technology,Inc., a leader in innovative medical devices, announced ... cervical total disc,replacement (TDR), NuNec Cervical Arthroplasty Device. ... Zou and Wenwen Wu in Beijing China, on,patients ...
... to $11.7 million, -- Quarterly Net Income Increases ... NEW YORK and HAIKOU, Hainan, China, May ... (OTC Bulletin Board: CPHI),which develops, manufactures, and markets ... its financial results,for the first quarter of 2008., ...
Cached Biology Technology:GlaxoSmithKline Commences Tender Offer to Acquire Sirtris Pharmaceuticals 2GlaxoSmithKline Commences Tender Offer to Acquire Sirtris Pharmaceuticals 3Pioneer(R) Surgical Technology Announces First Human Implants of its NuNec(TM) Cervical Arthroplasty Device 2China Pharma Holdings, Inc. Announces First Quarter 2008 Financial Results 2China Pharma Holdings, Inc. Announces First Quarter 2008 Financial Results 3China Pharma Holdings, Inc. Announces First Quarter 2008 Financial Results 4China Pharma Holdings, Inc. Announces First Quarter 2008 Financial Results 5China Pharma Holdings, Inc. Announces First Quarter 2008 Financial Results 6China Pharma Holdings, Inc. Announces First Quarter 2008 Financial Results 7China Pharma Holdings, Inc. Announces First Quarter 2008 Financial Results 8China Pharma Holdings, Inc. Announces First Quarter 2008 Financial Results 9
(Date:6/19/2013)... The Microbial Diversity Course at the Marine Biological ... a Milestones in Microbiology site by the American ... in Microbiology program recognizes institutions and the scientists ... toward advancing the science of microbiology. A ... site is scheduled for Saturday, June 22, 2013, ...
(Date:6/19/2013)... June 19, 2013 AT&T * ... upcoming launch of the ultimate workhorse among ruggedized ... As one of the most ruggedized phones equipped ... Terrain embodies toughened versatility and business-ready features.  Its ... keep workforces moving forward, while also keeping up ...
(Date:6/19/2013)... A new variety of canary seeds bred specifically for ... be ideal for people with celiac disease (CD), scientists ... Journal of Agricultural and Food Chemistry . , ... least 3 million people in the United States alone ... eating wheat, barley, rye and other grains that contain ...
Breaking Biology News(10 mins):Microbial diversity course designated as a 'Milestones in Microbiology' site 2AT&T and NEC Introduce Ultra-Rugged Smartphone Designed for Hard Work, Real Life 2AT&T and NEC Introduce Ultra-Rugged Smartphone Designed for Hard Work, Real Life 3AT&T and NEC Introduce Ultra-Rugged Smartphone Designed for Hard Work, Real Life 4AT&T and NEC Introduce Ultra-Rugged Smartphone Designed for Hard Work, Real Life 5
... across Europe are embarking on new research to develop a ... million EU citizens and there is no cure," says Dr ... partner in the Food Allergy Specific Therapy (FAST) research project. ... foods to which they are allergic. The threat of severe ...
... Biology are pleased to announce that Dr Audrey ... of this year,s JEB Outstanding Paper Prize. The award ... Journal of Experimental Biology at http://jeb.biologists.org ., ... young scientist to an exceptional research paper. Dussutour was ...
... environmental threat has been detected in North American ... Along with scientists from several Canadian government ... by declining levels of calcium in many temperate, ... Queen,s PhD candidate Adam Jeziorski, lead author of ...
Cached Biology News:Scientists developing food allergy treatment 2French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 3Queen's University biologists find new environmental threat in North American lakes 2
... Epithelial and endothelial cells-directed ... a RGD peptide-conjugated polyethylenimine which ... integrin-expressing epithelial and endothelial cells. ... in cell-cell and cell-matrix adhesion ...
... WinMelt software is used to ... any DNA sequence up to ... optimizing placement of primers and ... by denaturing gradient gel electrophoresis ...
Request Info...
... Accurate To score SNPs, ... sequencing, the gold standard in DNA analysis. ... The polymorphic locus can be confirmed by ... DNA sequencing also provides sequence context information, ...
Biology Products: